CHEBI:5292 - geldanamycin

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name geldanamycin
ChEBI ID CHEBI:5292
Definition An ansamycin consisting of a 19-membered macrocyle incorporating a benzoquinone ring and a lactam functionality. It shows antimicrobial activity against many Gram-positive and some Gram-negative bacteria.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:42670
Supplier Information ChemicalBook:CB8462842, eMolecules:30154536, eMolecules:1934769, eMolecules:36500472, ZINC000100064834
Download Molfile XML SDF
more structures >>
Wikipedia License
Geldanamycin is a 1,4-benzoquinone ansamycin antitumor antibiotic that inhibits the function of Hsp90 (Heat Shock Protein 90) by binding to the unusual ADP/ATP-binding pocket of the protein. HSP90 client proteins play important roles in the regulation of the cell cycle, cell growth, cell survival, apoptosis, angiogenesis and oncogenesis. Geldanamycin induces the degradation of proteins that are mutated or overexpressed in tumor cells such as v-Src, Bcr-Abl, p53, and ERBB2. This effect is mediated via HSP90. Despite its potent antitumor potential, geldanamycin presents several major drawbacks as a drug candidate such as hepatotoxicity, further, Jilani et al.. reported that geldanamycin induces the apoptosis of erythrocytes under physiological concentrations. These side effects have led to the development of geldanamycin analogues, in particular analogues containing a derivatisation at the 17 position: 17-AAG 17-DMAG
Read full article at Wikipedia
Formula C29H40N2O9
Net Charge 0
Average Mass 560.63590
Monoisotopic Mass 560.27338
InChI InChI=1S/C29H40N2O9/c1-15-11-19-25(34)20(14-21(32)27(19)39-7)31-28(35)16(2)9-8-10-22(37-5)26(40-29(30)36)18(4)13-17(3)24(33)23(12-15)38-6/h8-10,13-15,17,22-24,26,33H,11-12H2,1-7H3,(H2,30,36)(H,31,35)/b10-8-,16-9+,18-13+/t15-,17+,22+,23+,24-,26+/m1/s1
InChIKey QTQAWLPCGQOSGP-KSRBKZBZSA-N
SMILES CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O
Roles Classification
Biological Role(s): antiviral agent
A substance that destroys or inhibits replication of viruses.
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
cysteine protease inhibitor
Any protease inhibitor that restricts the action of a cysteine protease.
Hsp90 inhibitor
An EC 3.6.4.10 (non-chaperonin molecular chaperone ATPase) inhibitor that blocks the action of heat shock protein 90.
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing geldanamycin (CHEBI:5292) has role antimicrobial agent (CHEBI:33281)
geldanamycin (CHEBI:5292) has role antineoplastic agent (CHEBI:35610)
geldanamycin (CHEBI:5292) has role antiviral agent (CHEBI:22587)
geldanamycin (CHEBI:5292) has role cysteine protease inhibitor (CHEBI:64152)
geldanamycin (CHEBI:5292) has role Hsp90 inhibitor (CHEBI:63962)
geldanamycin (CHEBI:5292) is a 1,4-benzoquinones (CHEBI:132124)
geldanamycin (CHEBI:5292) is a ansamycin (CHEBI:22565)
geldanamycin (CHEBI:5292) is a carbamate ester (CHEBI:23003)
geldanamycin (CHEBI:5292) is a organic heterobicyclic compound (CHEBI:27171)
Incoming alvespimycin (CHEBI:65324) has functional parent geldanamycin (CHEBI:5292)
retaspimycin (CHEBI:71975) has functional parent geldanamycin (CHEBI:5292)
tanespimycin (CHEBI:64153) has functional parent geldanamycin (CHEBI:5292)
IUPAC Name
(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
Synonyms Sources
GELDANAMYCIN PDBeChem
Geldanamycin KEGG COMPOUND
Manual Xrefs Databases
C00018795 KNApSAcK
C11222 KEGG COMPOUND
GDM PDBeChem
Geldanamycin Wikipedia
View more database links
Registry Numbers Types Sources
14205884 Reaxys Registry Number Reaxys
30562-34-6 CAS Registry Number ChemIDplus
Citations
McNamara AV, Barclay M, Watson AJ, Jenkins JR (2012)
Hsp90 inhibitors sensitise human colon cancer cells to topoisomerase I poisons by depletion of key anti-apoptotic and cell cycle checkpoint proteins.
Biochemical pharmacology 83, 355-367 [PubMed:22138446]
[show Abstract]
Haupt A, Joberty G, Bantscheff M, Fröhlich H, Stehr H, Schweiger MR, Fischer A, Kerick M, Boerno ST, Dahl A, Lappe M, Lehrach H, Gonzalez C, Drewes G, Lange BM (2012)
Hsp90 inhibition differentially destabilises MAP kinase and TGF-beta signalling components in cancer cells revealed by kinase-targeted chemoproteomics.
BMC cancer 12, 38 [PubMed:22277058]
[show Abstract]
Neckers L, Workman P (2012)
Hsp90 molecular chaperone inhibitors: are we there yet?
Clinical cancer research : an official journal of the American Association for Cancer Research 18, 64-76 [PubMed:22215907]
[show Abstract]
Sultana R, Theodoraki MA, Caplan AJ (2012)
UBR1 promotes protein kinase quality control and sensitizes cells to Hsp90 inhibition.
Experimental cell research 318, 53-60 [PubMed:21983172]
[show Abstract]
Chen WW, Yu H, Fan HB, Zhang CC, Zhang M, Zhang C, Cheng Y, Kong J, Liu CF, Geng D, Xu X (2012)
RIP1 mediates the protection of geldanamycin on neuronal injury induced by oxygen-glucose deprivation combined with zVAD in primary cortical neurons.
Journal of neurochemistry 120, 70-77 [PubMed:21985437]
[show Abstract]
Eichner S, Eichner T, Floss HG, Fohrer J, Hofer E, Sasse F, Zeilinger C, Kirschning A (2012)
Broad substrate specificity of the amide synthase in S. hygroscopicus--new 20-membered macrolactones derived from geldanamycin.
Journal of the American Chemical Society 134, 1673-1679 [PubMed:22136518]
[show Abstract]
Mout R, Xu ZD, Wolf AK, Jo Davisson V, Jarori GK (2012)
Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii.
Malaria journal 11, 54 [PubMed:22361388]
[show Abstract]
Wu X, Tao P, Nie H (2011)
Geldanamycin is effective in the treatment of herpes simplex virus epithelial keratitis in a rabbit model.
Clinical & experimental ophthalmology 39, 779-783 [PubMed:22050565]
[show Abstract]
Last Modified
02 June 2016